INTERLEUKIN-1-BETA-MEDIATED AND TUMOR NECROSIS FACTOR-ALPHA-MEDIATED REGULATION OF ICAM-1 GENE-EXPRESSION IN ASTROCYTES REQUIRES PROTEIN-KINASE-C ACTIVITY
Me. Ballestas et En. Benveniste, INTERLEUKIN-1-BETA-MEDIATED AND TUMOR NECROSIS FACTOR-ALPHA-MEDIATED REGULATION OF ICAM-1 GENE-EXPRESSION IN ASTROCYTES REQUIRES PROTEIN-KINASE-C ACTIVITY, Glia, 14(4), 1995, pp. 267-278
Several adhesion molecules including intercellular adhesion molecule-1
(ICAM-1) are expressed by astrocytes, the predominant glial cell of t
he central nervous system (CNS). Such molecules are important in the t
rafficking of leukocytes to sites of inflammation, and in lymphocyte a
ctivation. ICAM-1 is constitutively expressed by neonatal rat astocyte
s, and expression is enhanced by the proinflammatory cytokines interle
ukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), and
interferon-gamma (IFN-gamma), with IL-1 beta and TNF-alpha being the s
trongest inducers. In this study, we have examined the nature of the s
econd messengers involved in ICAM-1 gene expression induced by the cyt
okines IL-1 beta and TNF-alpha. Our results indicate that stimuli rela
ted to protein kinase C (PKC) such as the phorbol ester phorbol 12-myr
istate 13-acetate (PMA) and calcium ionophore A23187 increase ICAM-1 m
RNA expression, whereas cyclic nucleotide analogs and PKA agonists hav
e no effect. Pharmacologic inhibitors of PKC such as H7, H8, and calph
ostin C inhibit ICAM-1 gene expression inducible by IL-1 beta and TNF-
alpha. Prolonged treatment of astrocytes with PMA results in a time-de
pendent downregulation of the PKC isoforms alpha, delta, and epsilon,
and a concomitant diminution of ICAM-1 mRNA expression induced by IL-1
beta, TNF-alpha, and PMA itself at specific time points post-PMA trea
tment. These data, collectively, demonstrate a role for various PKC is
oforms in IL-1 beta and TNF-alpha enhancement of ICAM-1 gene expressio
n in rat astrocytes. (C) 1995 Wiley-Liss, Inc.